Skip to main content
Tech.eu· John Reynolds·· 1 days agoTop DealsAI Score80

London-based Boltz raises $110M Series A for AI drug discovery

London-based Boltz raises $110M Series A

AI Overview

London-based AI drug discovery startup Boltz raised a $110M Series A led by Bessemer Venture Partners.

Why it matters

Boltz's $110M Series A, led by Bessemer less than a year after leaving stealth, shows how quickly open-source protein-structure models are turning into funded drug-discovery platforms.

Source:Tech.eu · tech.eu

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing